The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Pharmacological Activation of Liver X Receptors Promotes Reverse Cholesterol Transport In Vivo
Abstract
Background— Liver X receptors (LXRs) are ligand-activated transcription factors involved in the control of lipid metabolism and inflammation. Synthetic LXR agonists have been shown to inhibit the progression of atherosclerosis in mice, but the mechanism is uncertain. LXR agonism upregulates the genes encoding ATP binding cassette transporters A1 (ABCA1) and G1 (ABCG1) in macrophages, thus promoting efflux of cholesterol; it also upregulates liver and intestinal ABCG5 and ABCG8, helping to promote biliary and fecal excretion of cholesterol. Thus, LXR agonism may inhibit atherosclerosis through promotion of reverse cholesterol transport (RCT) in vivo, but this has not been proven. We previously described an in vivo method to trace the movement of cholesterol from 3 H-cholesterol–labeled J774 macrophages into plasma, into liver, and ultimately into the bile and feces as free cholesterol or bile acids. In the present study we used this approach to test the hypothesis that administration of the synthetic LXR agonist GW3965 would increase the rate of macrophage RCT in vivo. Methods and Results— Three different mouse models—wild-type C57BL/6 mice, LDLR/apobec-1 double knockout mice, and human apolipoprotein (apo)B/cholesteryl ester transfer protein (CETP) double transgenic mice—were treated with either vehicle or GW3965. Mice were injected intraperitoneally with 3 H-cholesterol–labeled and cholesterol-loaded macrophages and monitored for the appearance of 3 H-tracer in plasma, liver, and feces. Administration of GW3965 significantly increased the levels of 3 H-tracer in plasma and feces in all 3 mouse models. Conclusions— These results demonstrate that administration of the LXR agonist GW3965 increases the rate of RCT from macrophages to feces in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Repa, J. J., Turley, S. D., Lobaccaro, J.-M. A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R. A., Dietschy, J. M., & Mangelsdorf, D. J. (2000) · Science · doi:10.1126/science.289.5484.1524 · Cited by 1,301
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G., Goodman, J., Hagger, G. N., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112059299 · Cited by 947
Self-citationKennedy, M. A., Barrera, G. C., Nakamura, K., Baldán, Á., Tarr, P., Fishbein, M. C., Frank, J., Francone, O. L., & Edwards, P. A. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.002 · Cited by 883
Repa, J. J., Berge, K. E., Pomajzl, C., Richardson, J. A., Hobbs, H., & Mangelsdorf, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109927200 · Cited by 852
Liver X Receptor Signaling Pathways in Cardiovascular Disease
Tontonoz, P., & Mangelsdorf, D. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0061 · Cited by 633
LXR-Dependent Gene Expression Is Important for Macrophage Survival and the Innate Immune Response
Joseph, S. B., Bradley, M. N., Castrillo, A., Bruhn, K. W., Mak, P. A., Pei, L., Hogenesch, J., O'Connell, R. M., Cheng, G., Saez, E., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.032 · Cited by 575
McNeish, J., Aiello, R. J., Guyot, D., Turi, T., Gabel, C., Aldinger, C., Hoppe, K. L., Roach, M. L., Royer, L. J., de Wet, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4245 · Cited by 537
HDL as a target in the treatment of atherosclerotic cardiovascular disease
Linsel-Nitschke, P., & Tall, A. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1658 · Cited by 486
Identification of macrophage liver X receptors as inhibitors of atherosclerosis
Tangirala, R. K., Bischoff, E. D., Joseph, S. B., Wagner, B. L., Walczak, R., Laffitte, B. A., Daige, C. L., Thomas, D., Heyman, R. A., Mangelsdorf, D. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182199799 · Cited by 438
Self-citationZhang, Y., Zanotti, I., Reilly, M. P., Glick, J. M., Rothblat, G. H., & Rader, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000086981.09834.e0 · Cited by 436
Self-citationCollins, J. L., Fivush, A. M., Watson, M. A., Galardi, C. M., Lewis, M. C., Moore, L. B., Parks, D. J., Wilson, J. G., Tippin, T. K., Binz, J. G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255116 · Cited by 434
ABC1 Gene Expression and ApoA-I-Mediated Cholesterol Efflux Are Regulated by LXR
Schwartz, K., Lawn, R. M., & Wade, D. P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3243 · Cited by 410
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice
Alberti, S., Schuster, G., Parini, P., Feltkamp, D., Diczfalusy, U., Rudling, M., Angelin, B., Björkhem, I., Pettersson, S., & Gustafsson, J.-′. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9794 · Cited by 367
PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis
Li, A. C., & Glass, C. K. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400010-jlr200 · Cited by 357
Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
Luo, Y., & Tall, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8573 · Cited by 351
Yu, L., York, J., von Bergmann, K., Lutjohann, D., Cohen, J. C., & Hobbs, H. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301311200 · Cited by 323
Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists
Levin, N., Bischoff, E. D., Daige, C. L., Thomas, D., Vu, C. T., Heyman, R. A., Tangirala, R. K., & Schulman, I. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150044.84012.68 · Cited by 284
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans
Schwartz, C. C., VandenBroek, J. M., & Cooper, P. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300511-jlr200 · Cited by 249
Plo¨sch, T., Kok, T., Bloks, V. W., Smit, M. J., Havinga, R., Chimini, G., Groen, A. K., & Kuipers, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206522200 · Cited by 207
Powell-Braxton, L., Véniant, M., Latvala, R. D., Hirano, K.-I., Won, W. B., Ross, J., Dybdal, N., Zlot, C. H., Young, S. G., & Davidson, N. O. (1998) · Nature Medicine · doi:10.1038/nm0898-934 · Cited by 192
Kruit, J. K., Plösch, T., Havinga, R., Boverhof, R., Groot, P. H. E., Groen, A. K., & Kuipers, F. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.006 · Cited by 161
Toll-Like Receptors, Endocrine Stress Response, and Arteriosclerosis
Bornstein, S. R., & Morawietz, H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000178996.91277.fb · Cited by 128
Liu, L., Bortnick, A. E., Nickel, M., Dhanasekaran, P., Subbaiah, P. V., Lund‐Katz, S., Rothblat, G. H., & Phillips, M. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308420200 · Cited by 122
Self-citationSynthetic LXR agonists increase LDL in CETP species
Groot, P. H. E., Pearce, N. J., Yates, J. W., Stocker, C. J., Sauermelch, C. F., Doe, C. P. A., Willette, R. N., Olzinski, A. R., Peters, T., d'Epagnier, D. L., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500116-jlr200 · Cited by 119
Self-citationGrass, D., Saini, U., Felkner, R. H., Wallace, R., Lago, W., Young, S. G., & Swanson, M. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39866-7 · Cited by 67
The ins and outs of reverse cholesterol transport
Groen, A. K., Elferink, R. P. J. O., Verkade, H. J., & Kuipers, F. (2004) · Annals of Medicine · doi:10.1080/07853890310020635 · Cited by 62
Cholesteryl Ester Transfer Protein Activity Enhances Plasma Cholesteryl Ester Formation
Oliveira, H. C. F., Ma, L., Milne, R. W., Marcovina, S. M., Inazu, A., Mabuchi, H., & Tall, A. R. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1045 · Cited by 56
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141
Rayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690
Molecular regulation of HDL metabolism and function: implications for novel therapies
Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 599
Self-citationThe role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
Rader, D. J., Alexander, E. T., Weibel, G. L., Billheimer, J., & Rothblat, G. H. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800088-jlr200 · Cited by 597
Self-citation
Metadata
- Authors
- Naik, S. U., Wang, X., Da Silva, J. S., Jaye, M., Macphee, C. H., Reilly, M. P., Billheimer, J. T., Rothblat, G. H., & Rader, D. J.
- Venue
- Circulation
- Published
- 2006-01-03
- Volume
- 113
- Issue
- 1
- Pages
- 90-97
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2018911114
- Cited by
- 378
- References
- 30
- FWCI
- 21.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.